请输入您要查询的百科知识:

 

词条 May–Hegglin anomaly
释义

  1. Presentation

  2. Pathogenesis

  3. Diagnosis

  4. Treatment

  5. History

  6. References

  7. External links

{{Infobox medical condition (new)
| name = May–Hegglin anomaly
| synonyms =
| image = May-Hegglin smear 2009-11-13.JPG
| caption =
| pronounce =
| field =
| symptoms =
| complications =
| onset =
| duration =
| types =
| causes =
| risks =
| diagnosis =
| differential =
| prevention =
| treatment =
| medication =
| prognosis =
| frequency =
| deaths =
}}

May–Hegglin anomaly (MHA), also known as Döhle leukocyte inclusions with giant platelets and macrothrombocytopenia with leukocyte inclusions,[1] is a rare genetic disorder of the blood platelets that causes them to be abnormally large.

Presentation

In the leukocytes, the presence of very small rods (around 3 micrometers), or Döhle-like bodies can be seen in the cytoplasm.

Pathogenesis

MHA is believed to be associated with the MYH9 gene.[2] The pathogenesis of the disorder had been unknown until recently, when autosomal dominant mutations in the gene encoding non-muscle myosin heavy chain IIA (MYH9) were identified. Unique cytoplasmic inclusion bodies are aggregates of nonmuscle myosin heavy chain IIA, and are only present in granulocytes. It is not yet known why inclusion bodies are not present in platelets, monocytes, and lymphocytes, or how giant platelets are formed. MYH9 is also found to be responsible for several related disorders with macrothrombocytopenia and leukocyte inclusions, including Sebastian, Fechtner, and Epstein syndromes, which feature deafness, nephritis, and/or cataract.[2] MHA is also a feature of the Alport syndrome (hereditary nephritis with sensorineural hearing loss).[3]

Diagnosis

{{Empty section|date=July 2018}}

Treatment

May-Hegglins Anomaly can be treated by various methods.

Medication;

Tranexamic Acid

Desmopressin Acetate

Platelet Transfusion will not work, because the affected platelets will overtake the new platelets.

History

MHA is named for German physician Richard May (January 7, 1863 – 1936) and Swiss physician Robert Hegglin.[4][5][6] The disorder was first described by Richard May in 1909 and was subsequently described by Robert Hegglin in 1945.

References

1. ^{{OMIM|155100}}
2. ^{{Cite journal| doi = 10.1002/ajh.21102| date=Apr 2008 | last1 = Saito | first1 = H.| last2 = Kunishima | first2 = S.| title = Historical hematology: May-Hegglin anomaly| volume = 83| issue = 4| pages = 304–306| issn = 0361-8609| pmid = 17975807| journal = American Journal of Hematology}}
3. ^Noris P et al. Thrombocytopenia, giant platelets, and leukocyte inclusion bodies (May-Hegglin anomaly): clinical and laboratory findings. Am J Med 1998;104(4):355-60
4. ^{{WhoNamedIt|synd|113}}
5. ^R. May. Leukocyteneinschlüsse. Kasuistische Mitteilung. Deutsches Archiv für klinische Medizin, Leipzig, 1909, 96: 1-6.
6. ^R. Hegglin. Über eine neue Form einer konstitutionellen Leukozytenanomalie, kombiniert mit Throbopathie. Schweizerische medizinische Wochenschrift, Basel, 1945, 75: 91-92.

External links

{{Medical resources
| DiseasesDB = 29517
| ICD10 = {{ICD10|D|72|0|d|70}}
| ICD9 = {{ICD9|288.2}}
| ICDO =
| OMIM = 155100
| MedlinePlus =
| eMedicineSubj = ped
| eMedicineTopic = 1383
| MeshID =
}}{{Diseases of megakaryocytes}}{{Cytoskeletal defects}}{{DEFAULTSORT:May-Hegglin anomaly}}

3 : Coagulopathies|Cytoskeletal defects|Rare diseases

随便看

 

开放百科全书收录14589846条英语、德语、日语等多语种百科知识,基本涵盖了大多数领域的百科知识,是一部内容自由、开放的电子版国际百科全书。

 

Copyright © 2023 OENC.NET All Rights Reserved
京ICP备2021023879号 更新时间:2024/11/12 23:35:32